Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Cancer Treatment Reviews|July 13, 2024
Peripheral T-cell lymphoma: From biology to practice to the futureOwen A O'Connor, Helen Ma, Jason Yong Sheng Chan, et al.
The Korean Journal of Internal Medicine|March 18, 2026
Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphomaChanggon Kim, Sang Eun Yoon, Hyun-Young Kim, et al.
Cancers|November 26, 2022
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell LymphomaSeok Jin Kim, Kyung Ju Ryu, Bon Park, et al.
BMC Cancer|February 15, 2020
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphomaInju Cho, Hansang Lee, Sang Eun Yoon, et al.
Frontiers in Oncology|February 6, 2023
Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphomaSun Young Jeong, Sang Eun Yoon, Duck Cho, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 3, 2025
Risk of suicide in cancer patients: nationwide cohort studyJung Eun Yoo, Wonyoung Jung, Jin Hyung Jung, et al.
Blood Research|April 22, 2025
Real-world data analysis of survival outcomes of patients with primary mediastinal large B-cell lymphoma treated with immunochemotherapy: the role of consolidative radiation therapyYong-Pyo Lee, Junhun Cho, Young Hyeh Ko, et al.
Annals of Hematology|May 31, 2022
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphomaYong-Pyo Lee, Sang Eun Yoon, Junhun Cho, et al.
BMC Cancer|November 1, 2025
Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator studyJu Hwan Kim, Sungho Bea, Yeeun Choi, et al.
Frontiers in Oncology|November 30, 2023
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphomaSang Eun Yoon, Sujin Park, Junhun Cho, et al.
Pageof 14